![A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/1ae03c15-793e-4a63-b12c-15a3f4ddc29c/emmm202215997-fig-0006-m.png)
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine
![A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/58892e9f-905a-4ee5-bdfd-de03dfa1b1ad/emmm202215997-fig-0001-m.png)
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine
![COVID: Nadir Arber, l'Israélien à l'origine de l'EXO-CD24, "médicament miracle" - The Times of Israël COVID: Nadir Arber, l'Israélien à l'origine de l'EXO-CD24, "médicament miracle" - The Times of Israël](https://static.timesofisrael.com/fr/uploads/2021/02/iStock-1205199983.jpg)
COVID: Nadir Arber, l'Israélien à l'origine de l'EXO-CD24, "médicament miracle" - The Times of Israël
![A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/fdc58944-8923-433c-8cff-105ad08c1901/emmm202215997-fig-0004-m.png)
A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond | EMBO Molecular Medicine
![Targeting CD24 as a novel immunotherapy for solid cancers | Cell Communication and Signaling | Full Text Targeting CD24 as a novel immunotherapy for solid cancers | Cell Communication and Signaling | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12964-023-01315-w/MediaObjects/12964_2023_1315_Fig1_HTML.png)
Targeting CD24 as a novel immunotherapy for solid cancers | Cell Communication and Signaling | Full Text
![Targeting CD24 as a novel immunotherapy for solid cancers | Cell Communication and Signaling | Full Text Targeting CD24 as a novel immunotherapy for solid cancers | Cell Communication and Signaling | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12964-023-01315-w/MediaObjects/12964_2023_1315_Fig2_HTML.png)
Targeting CD24 as a novel immunotherapy for solid cancers | Cell Communication and Signaling | Full Text
![IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease](https://www.mdpi.com/ijms/ijms-25-00077/article_deploy/html/images/ijms-25-00077-g004-550.jpg)
IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease
![Radio Cadena Voces on X: "#RCVInternacional El tratamiento, llamado EXO-CD24, es administrado directo a los pulmones para eliminar daños generados por covid Dato: 29 de 30 pacientes con COVID-19 en condición moderada Radio Cadena Voces on X: "#RCVInternacional El tratamiento, llamado EXO-CD24, es administrado directo a los pulmones para eliminar daños generados por covid Dato: 29 de 30 pacientes con COVID-19 en condición moderada](https://pbs.twimg.com/media/Eu1weFVWYAEJ-3A.jpg)
Radio Cadena Voces on X: "#RCVInternacional El tratamiento, llamado EXO-CD24, es administrado directo a los pulmones para eliminar daños generados por covid Dato: 29 de 30 pacientes con COVID-19 en condición moderada
![IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease](https://www.mdpi.com/ijms/ijms-25-00077/article_deploy/html/images/ijms-25-00077-g001.png)
IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease
![IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease IJMS | Free Full-Text | Inhaled CD24-Enriched Exosomes (EXO-CD24) as a Novel Immune Modulator in Respiratory Disease](https://www.mdpi.com/ijms/ijms-25-00077/article_deploy/html/images/ijms-25-00077-g003.png)